Related Experiment Video
Updated: Mar 26, 2026

08:57
Production of Recombinant PRMT Proteins using the Baculovirus Expression Vector System
Published on: July 17, 2021
8.5K
Recombinant Protein Production in Large-Scale Agitated Bioreactors Using the Baculovirus Expression Vector System
Christine M Thompson1,2, Johnny Montes2, Marc G Aucoin3
1Department of Chemical Engineering, Ecole Polytechnique de Montreal, 2500 Chemin de Polytechnique, Montreal, Canada.
Methods in Molecular Biology (Clifton, N.J.)
|January 29, 2016
Summary
This chapter details recombinant protein production using the baculovirus expression vector system (BEVS) in large bioreactors. It covers batch process methods from cell growth to product recovery, including advanced monitoring and control strategies.
Area of Science:
- Biotechnology
- Molecular Biology
- Bioprocess Engineering
Background:
- The baculovirus expression vector system (BEVS) is a powerful tool for recombinant protein production.
- Large-scale production in agitated bioreactors presents unique challenges for BEVS applications.
Purpose of the Study:
- To provide a comprehensive overview of the methods for large-scale recombinant protein production using BEVS in agitated bioreactors.
- To detail the critical stages of a batch process for efficient protein recovery.
Main Methods:
- Host cell cultivation and virus stock amplification and quantification.
- Bioreactor preparation, operation, and the infection process.
- Product harvesting and primary separation techniques, including on-line monitoring and control.
Main Results:
- Detailed methodologies for each stage of the BEVS batch process are presented.
- The importance of advanced on-line monitoring and bioreactor control for process success is highlighted.
Conclusions:
- Successful large-scale recombinant protein production using BEVS requires careful optimization of each process step.
- Integration of advanced monitoring and control enhances overall process efficiency and product yield.
Related Concept Videos
Upstream Processing
36
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
36
Production of Biopesticides
57
Biopesticides offer a sustainable alternative to chemical pesticides, utilizing microbial agents to control agricultural pests. Bacillus thuringiensis (Bt) is a widely employed bacterium known for its potent insecticidal activity. Bt biopesticides are favored for their specificity to insect pests, minimal environmental impact, and natural degradability.Mechanism of Bt Toxin Action Bt produces insecticidal crystal (Cry) proteins during its sporulation phase. These proteins form parasporal...
57
Recombinant DNA
104.8K
Overview
104.8K
Production of Pharmaceuticals
26
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
26

